Oxford Biomedica Confirms Aura Biosciences Partnership For Phase 3 Eye Cancer Drug Manufacturing NASDAQ · Markets 36m ago
Kaynes Technology shares extend losses, fall another 4%; should investors worry about its Q2 performance? LiveMint · Markets 38m ago
Fraser And Neave FY26 Attributable Profit Rises, Despite Weak Revenues; Sees Challenging FY27 NASDAQ · Markets 42m ago
NSE or BSE: Why are experts bullish on NSE shares? Here's what technical charts hint at? | Target price, stop-loss LiveMint · Markets 47m ago
Jio Platforms, BLS Polymers, Shiprocket, more: 23 stocks to watch as anchor lock-in expires this week | List LiveMint · Markets Video 51m ago
SpaceX Has 33 Analysts Covering It and Just 1 "Strong Sell." Here’s What That Analyst Sees That the Other 32 Don’t. NASDAQ · Markets 52m ago